reduce pain after laparoscopic gynecological procedures
Phase 3
Recruiting
- Conditions
- T88.9The effects of the combination of ropivacaine and ketamine, pain reduction, laparoscopic surgeries for women.Complication of surgical and medical care, unspecified
- Registration Number
- IRCT20221117056529N1
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 50
Inclusion Criteria
II or I ASA class , candidates for laparoscopic surgery for women in the age range of 18-60 years in Al-Zahra Hospital, Tabriz
Patient consent to enter the study
Exclusion Criteria
The existence of any contraindications to the use of ropivacaine and other local anesthetics
The presence of any contraindications for ketamine use: history of seizures, psychological disorders, hypertension, high intracerebral pressure, etc.
Hypersensitivity to ropivacaine or other local anesthetics and ketamine
Concomitant systemic diseases such as any history of cardiovascular, pulmonary, liver, kidney, etc.
Presence of chronic pain in the patient
Addiction to the use of painkillers and drugs
Patient dissatisfaction
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The percentage of people in whom abdominal and shoulder pain has decreased after laparoscopic surgeries. Timepoint: Upon entering the operating room, standard monitoring including NIBP, HR, RR, ECG, SPO2, and ETCo2 is done and will continue. The severity of shoulder and abdominal pain is recorded every 15 minutes until the patient's complete recovery and delivery to the ward. Method of measurement: The severity of shoulder and abdominal pain, based on VAS score and degree of sedation according to Ramsay sedation score, is recorded every 15 minutes until the patient's complete recovery and delivery to the ward.
- Secondary Outcome Measures
Name Time Method